Glaucoma Treatment Market is projected to grow at a 3.2% CAGR and reach USD 8 Billion by 2033 | FMI Study

The battle against glaucoma is gaining traction, with the global Glaucoma Treatment Market poised for significant growth. Currently valued at USD 5.7 billion in 2022, the market is projected to reach a substantial USD 8 billion by 2033, reflecting a steady Compound Annual Growth Rate (CAGR) of 3.2%. The elderly population is more into getting …

Global Glaucoma Treatment Industry is projected to develop at a steady 3.2% CAGR to reach US$ 8 Billion By 2033 | FMI Study

The Global Glaucoma Treatment Industry is poised for continued expansion over the next decade, according to a recent market analysis by Future Market Insights (FMI). The market, currently valued at approximately US$5.7 billion at the end of 2022, is expected to experience a steady Compound Annual Growth Rate (CAGR) of 3.2%. This growth trajectory is …

Global Glaucoma Treatment Industry Aims for US$ 8 Billion by 2033, with FMI projecting a steady 3.2% CAGR growth

The Global Glaucoma Treatment Industry, currently valued at US$ 5.7 billion as of the end of 2022, is poised for substantial growth. Projections indicate a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period from 2023 to 2033. By the end of 2033, the market is expected to reach a value of approximately US$ 8.0 billion The prevalence of glaucoma among the elderly …

Glaucoma Treatment Industry Set to Reach US$ 8 Billion by 2033, FMI Predicts 3.2% CAGR Growth | FMI

The global Glaucoma Treatment Industry holds a valuation of US$ 5.7 Billion by the end of the year 2022. During the forecast period of 2023 to 2033, the market is expected to grow at a CAGR of 3.2%, with a market value of around US$ 8.0 billion in 2033. The elderly population is more into getting infected …

Projected value of the Glaucoma Treatment Market is expected to be US$ 7.78 Bn by 2032

According to Future Market Insights (FMI), the Glaucoma Treatment Market is forecasted to reach a net worth of US$ 7.6 Bn in 2032 from US$ 5.5 Bn in 2021 by registering a moderate CAGR of 3%. With the increasing proportion of the geriatric population in different geographic regions, glaucoma has emerged as a prevalent ailment. Request a report sample to gain comprehensive insights@ …